Intellectual property and the pharmaceutical industry: A moral crossroads between health and property
Journal of Business Ethics 55 (3) (2004)
|Abstract||The moral justification of intellectual property is often called into question when placed in the context of pharmaceutical patents and global health concerns. The theoretical accounts of both John Rawls and Robert Nozick provide an excellent ethical framework from which such questions can be clarified. While Nozick upholds an individuals right to intellectual property, based upon its conformation with Lockean notions of property and Nozicks ideas of just acquisition and transfer, Rawls emphasizes the importance of basic liberties, such as an individuals right to health, superceding such secondary rights as intellectual property rights. From a policy perspective, patent protection for pharmaceutical products necessarily entails the balancing of corporate intellectual property interests and public interests in healthcare. The moral dilemma that occurs when these two interests clash is not easily resolved. Aside from corporate and public interests, the state maintains an interest in creating and preserving policies that regulate the moral dilemma itself. This paper analyzes the economic and ethical factors surrounding the production and distribution of the anti-HIV medication, AZT. Potential policy implications and recommendations are also discussed|
|Keywords||No keywords specified (fix it)|
|Through your library||Configure|
Similar books and articles
David Lea (2006). From the Wright Brothers to Microsoft: Issues in the Moral Grounding of Intellectual Property Rights. Business Ethics Quarterly 16 (4):579-598.
James Wilson (2009). Could There Be a Right to Own Intellectual Property? Law and Philosophy 28 (4):393 - 427.
Kenneth Einar Himma (2011). Richard Spinello and Maria Bottis: Understanding the Debate on the Legal Protection of Moral Intellectual Property Interests: Review Essay of A Defense of Intellectual Property Rights. Ethics and Information Technology 13 (3):283-288.
Joseph Millum (2008). Are Pharmaceutical Patents Protected by Human Rights? Journal of Medical Ethics 34 (11):e25-e25.
D. B. Resnik (2003). A Pluralistic Account of Intellectual Property. Journal of Business Ethics 46 (4):319 - 335.
Meri Koivusalo (2010). Common Health Policy Interests and the Shaping of Global Pharmaceutical Policies. Ethics and International Affairs 24 (4):395-414.
Nevin M. Gewertz & Rivka Amado (2004). Intellectual Property and the Pharmaceutical Industry: A Moral Crossroads Between Health and Property. Journal of Business Ethics 55 (3):295 - 308.
Added to index2009-01-28
Total downloads87 ( #8,293 of 549,084 )
Recent downloads (6 months)19 ( #3,054 of 549,084 )
How can I increase my downloads?